General Information:
- Abstracts will be considered for oral or poster (Electronic) presentation.
- Abstracts must be submitted in English.
- Abstracts should be submitted by attaching either an MS Word document or PDF file to the email below.
- The abstract should be between 150-250 words.
- Font face: Times New Roman, Size: 12 points.
- List a maximum of 5 keywords.
- Ensure abstracts are not sent via any other method (e.g., through the FB page).
Free Communications:
- Structured format for Free Communications:
- Title
- Authors (maximum of six) and Affiliations including Country
- Introduction
- Objectives
- Method
- Results
- Conclusion
- Conflict(s) of interest.
- Deadline for Free Communications: 20 April ,2024
- State if the abstract has been submitted elsewhere.
- All abstracts subject to approval by the Scientific Program Committee.
- Presenting authors of accepted abstracts must be registered to attend AICFM 2024
Oral Presentations:
- Duration: 10 minutes for presentation, plus an extra 5 minutes for questions & discussion (Total: 15 minutes).
- Presentation Slides: MS PowerPoint format, to be sent to the email below after approval by the scientific committee.
- Submission Deadline: On or before 20 April ,2024 , after approval by the Scientific Committee.
Poster Presentations :
- Format: Posters will be displayed electronically (specific format will be notified later).
Submission Email:
abstracts@efmf-eg.orgAbstract Topics for 2024 Submission
#### Obstetrics
1. **Pregnancy Complications Screening**
- Screening for stillbirth, preterm birth, and pre-eclampsia throughout pregnancy trimesters.
2. **Chromosomal Anomalies Screening**
- Including cfDNA, genomics, and gene therapy screening in the first trimester and beyond.
3. **Fetal Brain and CNS Anomalies**
- Evaluation of normal brain/CNS development and screening for anomalies from early to late pregnancy.
4. **Fetal Heart, CHD, and Cardiac Functions**
- Evaluation of normal heart development and screening for Congenital Heart Disease (CHD) from early to late pregnancy.
5. **Fetal Disease and Structural Abnormalities**
- Evaluation of fetal anatomy and screening for structural abnormalities and syndromes involving various organs.
6. **Fetal Growth: Normal and Abnormal**
- Evaluation of biometry, size, and growth, and management of related issues such as Doppler, IUGR, and pre-eclampsia.
7. **Multiple Pregnancy**
- Management of multiple pregnancies (mono or dichorionic) through ultrasound-based approaches, excluding fetal interventions.
8. **Placenta Anomalies**
- Including spectrum of placenta accreta disorders, cord/placental anomalies, and abnormally invasive placenta.
9. **Ultrasound in the Labour Ward**
- Utilization of ultrasound before, during, or immediately after delivery in the labour ward.
10. **Fetal Interventions**
- Medical therapy, surgical interventions, and other interventions for various fetal conditions.
11. **Artificial Intelligence, Education, Simulation, Safety, and Innovations**
- Training, safety measures, and technical innovations in ultrasound examinations.
12. **Fetal and Maternal Infections including Coronavirus**
- Impact of COVID-19 and other infections on fetal and maternal health.
13. **Maternal Medicine**
- Maternal diseases affecting pregnancy outcomes.
#### Gynecology
14. **Early Pregnancy**
- Diagnosis and management of early pregnancy complications.
15. **Managing Ovarian Masses**
- Use of ultrasound for classifying ovarian and adnexal pathology.
16. **Pelvic Pain and Endometriosis**
- Work related to endometriosis and other causes of pelvic pain.
17. **Ultrasound and Fertility**
- Ultrasound-guided interventions for fertility preservation and management.
18. **Bleeding, Endometrial, and Myometrial Pathology**
- Assessment and diagnosis of various pathologies including fibroids, polyps, and endometrial carcinoma.
19. **Imaging in Oncology**
- Utilization of ultrasound in managing gynecological malignancies.
20. **Urogynecology and Ultrasound Guided Procedures**
- Use of ultrasound in urogynecology and related procedures.
**Note:** Further details regarding the electronic format for posters will be provided at a later date.
Thank you for your submission!